Latisse May Be Useful When Implemented For Baldness Therapy

Many women with short or non-existent eyelashes have been helped by a product called Latisse, which is manufactured by the same company that makes the popular injectable Botox. Allergan is currently testing the product on men and women against placebo to see what effects it has, but there is already significant proof that Latisse may have an effect on baldness.

This is not the first time that Allergan has discovered that one of their products had a handy side effect. Botox was originally approved for theraputic use in 1999, but its abilities to smooth wrinkles were not identified until later down the line. Today, Botox has scored $1.42 billion dollars in revenue in 2010 alone.

Latisse was actually licensed for theraputic use at first as well, and when patients with glaucoma in one eye started to notice their lashes growing longer, Allergan realized the product had other properties.

If Latisse can prove that it has what it takes to make hair growth happen on the head as well as with eyelashes, Allergan estimates it can make an additional $200-$500 million in sales from the product between now and the year 2020. There will always be plenty of people on the lookout for an efficient hair loss solution, so perhaps this means there’s a new one on the way. If you are looking for Botox Pittsburgh friends will never even know you had, check out your local options today.